Enregistrement - Lobbyistes-conseils

Objets

• Commerce international
• Industrie
• Propriété intellectuelle
• Questions touchant les consommateurs
• Relations internationales
• Santé
• Sciences et technologies

Détails sur l'objet

Politique ou Programme

• Canada's Food and Consumer Safety Action Plan, specifically proposed legislation and regulation with repect to therapeutic products
• Federal Health Partnership with respect to the coordination of federal drug plan policies and programs
• Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
• Health Canada Blueprint for Renewal: Modernizing Regulatory System for Health Products and Food (formerly Bill C-51)
• National Pharmaceuticals Strategy, particularly with respect to Health Canada policies and programs on a common formulary
• National Pharmaceuticals Strategy, particularly with respect to Health Canada policies and programs on catastrophic drug coverage
• National Pharmaceuticals Strategy, particularly with respect to Health Canada policies and programs on expensive drugs for rare diseases
• National Pharmaceuticals Strategy, particularly with respect to Health Canada policies and programs on pricing and purchasing strategies
• Patent Act as it relates to the regulation of intellectual property for therapeutic products
• Patented Medicines Prices Review Board with respect to amendments to the guidelines for the regulation of pricing of patented drug products patentees
• Patented Medicines Prices Review Board with respect to decisions on the reporting obligations of patented drug products patentees
• Proposed and potential policies with respect to current or potential regulation of cross-border trade in pharmaceuticals, including the Export Control List
• Science and Technology Strategy led by Industry Canada, particularly with respect to the life sciences priority under the S&T Strategy

Règlement

• Food and Drugs Act Regulations with respect to Data Protection under C.08.004.
• Food and Drugs Act Regulations, specficially with respect to approval, regulation and life-cycle management of therapeutic products
• Medical Devices Regulations under the Food and Drugs Act, specifically with respect to the approval, regulation and life cycle management of medical devices
• Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically proposed amendments to the Patented Medicines (Notice of Compliance) Regulations.
• Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations.

Techniques de communication

• Communication écrite
• Communication orale

Institutions gouvernementales

• Conseil d'examen du prix des médicaments brevetés (CEPMB)
• Industrie Canada
• Santé Canada (SC)

Adresse :
110 COCHRANE ROAD
MARKHAM, ON  L3R 9S1
Canada

Numéro de téléphone : 905-940-7164

Représentant du client

Mark Gilmour, Regulatory Affairs Manager

Renseignements sur la société mère